Literature DB >> 15224273

Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?

Lawrence A Labbate1, Susan C Sonne, Carrie L Randal, Raymond F Anton, Kathleen T Brady.   

Abstract

Post-traumatic stress disorder (PTSD) is commonly comorbid with other psychiatric disorders, including substance use disorders. In spite of this, pharmacologic treatment trials for PTSD often exclude individuals with significant psychiatric comorbidity. This study is a post hoc analysis of a 12-week double-blind placebo-controlled trial investigating sertraline in the treatment of patients with comorbid PTSD and an alcohol use disorder. Individuals with additional anxiety and affective disorders were included. Patients (N = 93) were stratified into four groups depending on presence or absence of additional anxiety or depressive disorders and evaluated for the effects of comorbidity on PTSD symptoms, depressive symptoms, and drinking behaviors. We hypothesized that additional comorbidity would be associated with poorer outcomes. Patients in all four subgroups showed marked and clinically significant improvement in alcohol drinking behaviors over the course of the study. For the entire sample, over the course of the 12 weeks, mean drinks per drinking day fell from 13.0 +/- 8.4 (SD) to 3.0 +/- 5.0 (SD); t = 10.2, df = 92, P <.000. There were, however, no significant differences among groups. Patients in all four groups showed moderate improvement in Hamilton Depression Rating Scale (HAMD) scores and Clinician-Administered PTSD scale (CAPS) scores at endpoint. For the entire sample, mean CAPS scores fell from 59.3 +/- 19.4 (SD) to 40.8 +/- 26.0, t = 8.9, df = 92, P <.000. Mean HAMD scores fell from 17. 9 +/- 6.7 (SD) at baseline to 11.8 +/- 9.4 (SD) at endpoint; t = 6.7, df = 92, P <.000. There were, however, no significant differences among groups for change in HAM-D or CAPS scores. Hence, contrary to our hypothesis, having additional anxiety or mood disorder comorbidity did not decrease treatment response in individuals with comorbid PTSD and an alcohol use disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224273     DOI: 10.1016/j.comppsych.2004.03.015

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  6 in total

Review 1.  Treatment of substance abusing patients with comorbid psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley; Antoine B Douaihy
Journal:  Addict Behav       Date:  2011-09-14       Impact factor: 3.913

Review 2.  Substance abuse in women.

Authors:  Shelly F Greenfield; Sudie E Back; Katie Lawson; Kathleen T Brady
Journal:  Psychiatr Clin North Am       Date:  2010-06

3.  Posttraumatic stress disorder and other psychopathology in substance abusing patients.

Authors:  John S Cacciola; Janelle M Koppenhaver; Arthur I Alterman; James R McKay
Journal:  Drug Alcohol Depend       Date:  2008-12-04       Impact factor: 4.492

Review 4.  Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Authors:  Jonathan C Ipser; Don Wilson; Taiwo O Akindipe; Carli Sager; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

Review 5.  Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.

Authors:  Roberta Agabio; Emanuela Trogu; Pier Paolo Pani
Journal:  Cochrane Database Syst Rev       Date:  2018-04-24

Review 6.  Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.

Authors:  Carmen Gimeno; Marisa Luisa Dorado; Carlos Roncero; Nestor Szerman; Pablo Vega; Vicent Balanzá-Martínez; F Javier Alvarez
Journal:  Front Psychiatry       Date:  2017-09-22       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.